EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseSystematische ÜbersichtÜbersichtsarbeit

HPV vaccination in people living with HIV : A network meta‐analysis highlighting safety, immunogenicity, and evidence gaps

Antonio Alves de Souza Neto, Amaxsell Thiago Barros de Souza, Ayane Cristine Alves Sarmento, Ana Katherine Gonçalves, Tolu Adedipe, Kleyton Santos de Medeiros, Janaina Cristiana de Oliveira Crispim

International Journal of Gynecology & Obstetrics · 2026-12 · 175 (3) · 1164-1176

DOI: 10.1002/ijgo.71153 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 20.06.2026. Verfasst von Antonio Alves de Souza Neto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Sciences Applied to Women's Health, Federal University of Rio Grande Do Norte, Natal, Brazil. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, HIV Infections. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HPV infection is a major contributor to cervical and other anogenital cancers, with people living with HIV (PLWH) at particularly high risk due to persistent infection. Although prophylactic HPV vaccines are widely used and generally safe, their efficacy and safety in PLWH remain uncertain.

Objective

To evaluate the efficacy and safety of HPV vaccination in PLWH through an overview and network meta‐analysis (NMA). Search Strategy An electronic search was conducted in several databases up to August 12, 2025, without date or language restrictions, using keywords related to HPV vaccines, efficacy, and safety. Selection Criteria We included systematic reviews of randomized controlled trials (RCTs) involving PLWH with HIV who received bivalent (bHPV), quadrivalent (qHPV), or nonavalent (9vHPV) HPV vaccines. Data Collection and Analysis Study selection (Rayyan software) and data extraction were conducted by two independent researchers, and discrepancies were resolved by a third author. Quantitative synthesis was performed using R software. Risk of bias was assessed using AMSTAR 2. The certainty of the evidence was assessed using the Confidence in Network Meta‐Analysis (CINeMA). Main Results NMA identified that the qHPV vaccine showed significant immunological efficacy, with a significant increase in seroconversion for anti‐HPV 6 (odds ratio [OR]: 17.72; 95% confidence interval [CI]: 2.55, 123.19) and anti‐HPV 18 (OR: 22.81; 95% CI: 2.31, 225.32) antibodies, compared to the control group. No significant differences were observed for types 11 and 16. Regarding safety, qHPV demonstrated the best profile regarding pain outcomes at all doses analyzed, with a P score greater than 0.98.

Conclusions

The qHPV vaccine presented the best safety profile regarding pain, including at all doses. Regarding immunological efficacy, significant differences were only found between patients vaccinated with qHPV for anti‐HPV 6 and 18. No trials directly evaluated the 9vHPV in PLWH, limiting the applicability of these findings to current vaccination programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesPapillomavirus InfectionsHIV InfectionsHumansFemaleRandomized Controlled Trials as TopicEvidence GapsVaccinationHuman Papillomavirus VirusesVaccine EfficacyImmunogenicity, VaccineUterine Cervical Neoplasms

Stichwörter der Autor:innen

HIVpapillomavirus vaccinesvaccine efficacy

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Postgraduate Program in Sciences Applied to Women's Health, Federal University of Rio Grande Do Norte, Natal, Brazil.
  • Institute of Education, Research, and Innovation, Liga Contra o Câncer, Natal, Brazil.
  • Postgraduate Program in Health Sciences, Federal University of Rio Grande Do Norte, Natal, Brazil.
  • Department of Obstetrics and Gynecology, Federal University of Rio Grande Do Norte, Natal, Brazil.
  • Women and Children's Hospital, Hull University Teaching Hospitals NHS Trust Humber Health Group Partnership, Hull, UK.
  • Department of Clinical and Toxicological Analysis, Federal University of Rio Grande Do Norte, Natal, Brazil.

Zitieren

APA

Neto, A. A. S., Souza, A. T. B., Sarmento, A. C. A., Gonçalves, A. K., Adedipe, T., de Medeiros, K. S., & Crispim, J. C. O. (2026). HPV vaccination in people living with HIV : A network meta‐analysis highlighting safety, immunogenicity, and evidence gaps. International Journal of Gynecology & Obstetrics, 175(3), 1164-1176. https://doi.org/10.1002/ijgo.71153

Vancouver

Neto AAS, Souza ATB, Sarmento ACA, Gonçalves AK, Adedipe T, de Medeiros KS, et al. HPV vaccination in people living with HIV : A network meta‐analysis highlighting safety, immunogenicity, and evidence gaps. International Journal of Gynecology & Obstetrics. 2026;175(3):1164-1176. doi:10.1002/ijgo.71153

BibTeX
@article{Neto2026,
  author = {Neto, Antonio Alves de Souza and Souza, Amaxsell Thiago Barros de and Sarmento, Ayane Cristine Alves and Gonçalves, Ana Katherine and Adedipe, Tolu and de Medeiros, Kleyton Santos and Crispim, Janaina Cristiana de Oliveira},
  title = {HPV vaccination in people living with HIV : A network meta‐analysis highlighting safety, immunogenicity, and evidence gaps},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  volume = {175},
  number = {3},
  pages = {1164--1176},
  doi = {10.1002/ijgo.71153}
}
Kostenlos starten →